ArticleInternational immunopharmacology2022

Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.

Luca Masotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.